PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143405
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143405
Feed Anticoccidials market size was valued at US$ 503.4 Million in 2025, expanding at a CAGR of 6.1% from 2026 to 2033.
Feed anticoccidials are one kind of medicated premix, which is added to the animal feed with the aim of preventing the occurrence of coccidiosis in animals, such as poultry and cattle. It can be achieved by inhibiting some of the metabolic pathways or the ion balance of the parasites in their endogenous developmental stages, as they ensure that the parasite lifecycle does not come to completion before they develop any symptoms. There are two main categories of feed anticoccidials, namely the polyether ionophores (monensin, salinomycin) and the synthetic non-ion feed anticoccidial (amprolium, decoquinate). They are administered using medicated feed, together with animal feed. Therefore, feed anticoccidials play an important role in ensuring disease prevention and enhancing the production efficiencies of livestock.
Feed Anticoccidials Market- Market Dynamics
Increasing Poultry Farming Operations to propel market demand
Expansion of poultry farms is the main factor behind the increase in coccidiosis, which is caused by the growth in production of poultry and an increased demand for meat. In June 2026, the Australian Bureau of Statistics (Gov) reported there was an increase in chicken slaughterings to 1.1 percent, amounting to 200.3 million. There was an increase in chicken meat production to 3.1 percent, reaching 409,119 tons during the quarter. Data on the ABS time series showed an increase in chicken slaughterings from 198.0 million in March 2026 to 200.3 million in June 2026 and an increase in chicken meat production from 397.0 thousand tonnes to 409.1 thousand tonnes. This is evident from the above figures indicating an increase in poultry processing and meat production during the June 2026 quarter. Thus, expansion of poultry farms requires effective coccidiosis prevention and flock health management.
The Global Feed Anticoccidials market is segmented on the basis of Livestock, Source, Type, and Region.
Based on livestock, poultry is widely used in the Feed Anticoccidials market because of increasing usage of anticoccidial feed additives to reduce and control coccidiosis as well as maximize the efficiency of feed and productivity in the poultry. In June 2026, Merck Animal Health signed a deal to purchase TARGAN, a biodevice company that focuses on disease prevention in the poultry industry, to expand its commercial poultry business and enhance precision ocular spray technology for administering coccidiosis vaccine to chicks within 1 day of hatch. Disease prevention and biosecurity are some of the factors that have become important for poultry producers who are opting for feed health management solutions. Moreover, development in the field of vaccines and delivery has made it feasible to control diseases and perform the flock efficiently. These trends are driving greater adoption of poultry health solutions and disease prevention practices.
Feed Anticoccidials Market- Geographical Insights
The Asia Pacific Feed Anticoccidials market is driven by the increase in poultry production, improved feed production facilities, and investments in livestock farming. In September 2026, according to APEDA (Gov), the egg production in India was found to be 149.11 billion eggs, which makes India the second largest egg producer in the world. Poultry production in India is caused by increased income, increased urbanization, a larger middle class, and the integrated production system.
The main states in India with respect to egg production are Andhra Pradesh (18.37%), Tamil Nadu (15.63%), Telangana (12.98%), West Bengal (10.72%), and Karnataka (6.67%), which contribute 64.37% to the total egg production in India. According to APEDA, the integrated production system, the chilled and frozen food products trend, and the cheap availability of corn and soybeans are the key drivers for the growth in India's poultry industry. Hence, poultry production and integrated farming systems are strengthening demand for feed anticoccidials across Asia Pacific.
North America benefits the use of advanced feeds and disease control measures for efficient agricultural processes. In August 2026, according to Innovation, Science and Economic Development Canada (Gov), in the Crop Production subsector (NAICS 111) in Canada, there were a total of 107,454 establishments within the Crop Production subsector (NAICS 111) of Canada in 2025, with 98.9% of them employing less than 100 workers. These include farms, orchards, greenhouses, and nurseries producing food crops, feed crops, and other crops with conventional, improved, or organic crop inputs. The Canadian crop production industry was exporting $30.1 billion and importing $14.1 billion of crops. This information can help support the expansion of agriculture in the country.
The feed anticoccidial companies include Phibro Animal Health Corporation, Zoetis Services LLC, Kemin Industries, Inc., Qilu Animal Health Products Co., Ltd., and Virbac S.A. These players are involved in the development of unique formulas and solutions for gut health, which is a major factor that boosts the market. Additionally, in order to meet the rising demand for products used for the reduction of the use of antibiotics, these firms are using novel technologies such as the encapsulation technique, premix customization, and low-dose formula, which help to improve the stability of their products. In April 2025, Phibro Animal Health Corporation received an approval from the U.S. FDA for Rumensin(TM) and V-Max(R) and for Experior(TM), Rumensin(TM) and V-Max(R) combinations used for the prevention and control of coccidiosis in cattle caused by Eimeria bovis and Eimeria zuernii. These strategies are shaping a more innovative and sustainable competitive scenario in feed anticoccidials.
In May 2026, Huvepharma and Qilu Tsingta made an announcement regarding their strategic partnership for the development and commercialization of cutting-edge coccidiosis vaccines.